OKYO Pharma (OKYO) Competitors

iTeos Therapeutics (NASDAQ:ITOS) and OKYO Pharma (NASDAQ:OKYO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

Do institutionals & insiders believe in ITOS or OKYO?

97.2% of iTeos Therapeutics shares are owned by institutional investors. Comparatively, 3.0% of OKYO Pharma shares are owned by institutional investors. 12.5% of iTeos Therapeutics shares are owned by company insiders. Comparatively, 40.5% of OKYO Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Which has more risk & volatility, ITOS or OKYO?

iTeos Therapeutics has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, OKYO Pharma has a beta of -0.32, indicating that its share price is 132% less volatile than the S&P 500.

Do analysts rate ITOS or OKYO?

iTeos Therapeutics presently has a consensus price target of $25.50, suggesting a potential upside of 251.72%. OKYO Pharma has a consensus price target of $7.00, suggesting a potential upside of 341.64%. Given OKYO Pharma's higher possible upside, analysts plainly believe OKYO Pharma is more favorable than iTeos Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iTeos Therapeutics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
OKYO Pharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is ITOS or OKYO more profitable?

OKYO Pharma's return on equity of 0.00% beat iTeos Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iTeos Therapeutics	N/A	-20.11%	-17.50%
OKYO Pharma	N/A	N/A	N/A

Does the media favor ITOS or OKYO?

In the previous week, iTeos Therapeutics had 3 more articles in the media than OKYO Pharma. MarketBeat recorded 8 mentions for iTeos Therapeutics and 5 mentions for OKYO Pharma. OKYO Pharma's average media sentiment score of 1.44 beat iTeos Therapeutics' score of 0.74 indicating that OKYO Pharma is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iTeos Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
OKYO Pharma	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in ITOS or OKYO?

iTeos Therapeutics received 37 more outperform votes than OKYO Pharma when rated by MarketBeat users. However, 100.00% of users gave OKYO Pharma an outperform vote while only 81.03% of users gave iTeos Therapeutics an outperform vote.

Company	Underperform	Outperform
iTeos Therapeutics	Outperform Votes 47 81.03%	Underperform Votes 11 18.97%
OKYO Pharma	Outperform Votes 10 100.00%	Underperform Votes No Votes

Which has preferable valuation & earnings, ITOS or OKYO?

OKYO Pharma has lower revenue, but higher earnings than iTeos Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iTeos Therapeutics	$35M	7.91	-$112.64M	-$3.31	-2.19
OKYO Pharma	N/A	N/A	-$16.83M	N/A	N/A

Summary

OKYO Pharma beats iTeos Therapeutics on 7 of the 13 factors compared between the two stocks.